Thermo Fisher Scientific (TMO)

NASDAQHealthcare

$631.57
+$12.65 (+2.0%)

January 21, 2026 at 19:17 UTC

Interactive Chart
TMO
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Thermo Fisher Scientific

Name

Thermo Fisher Scientific

CEO

Marc N. Casper

Industry

Healthcare

Year Founded

2006

Employees

125,000

Thermo Fisher Scientific Inc. is a life-science tools and services company that helps laboratories, manufacturers, and health systems turn experiments into routine outcomes. It supplies technology and know-how for sample preparation, measurement, and regulated production, with delivery models that range from instruments on site to outsourced scientific services. The approach is practical: keep methods consistent, documentation clear, and supply reliable so work can move from discovery to everyday use without constant reinvention. Teams support customers in research, diagnostics, and bioproduction, aligning procedures with standards that travel across regions. By pairing science with service, the company positions itself as infrastructure for modern laboratories and plants rather than a single product bet, aiming to make complex workflows feel predictable in real settings.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 12 Buy, 7 Hold, 2 Sell
Buy12
Hold7
Sell2
Fundamentals & Financials
Revenue (TTM)
$43.7B
Net Income (TTM)
$6.5B
EPS (TTM)
$17.34
ROA (TTM)
6.38%
Current Ratio
1.5
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue$11,122M
Cost of Sales$6,470M
Gross Profit$4,652M
Operating Income$1,943M
Net Income$1,616M
EPS$4.28
Technical Indicators

Thermo Fisher Scientific's Technical Indicators Summary

TMO is currently trading just above its key moving averages, including the 10-day and 200-day EMAs, which generally indicates a bullish trend. Momentum indicators such as the MACD and short-term moving averages support this positive outlook, while the RSI and CCI remain in moderate territory, suggesting neither overbought nor oversold conditions. However, the ADX near 24 points to only a modest trend strength, and the declining On-Balance Volume signals some selling pressure despite stable price levels. Volatility, as measured by the ATR, remains steady, and with the session closed, there is no VWAP data to influence intraday interpretation. Overall, the technical landscape for TMO reflects a balanced stance between upward momentum and caution from volume dynamics.

Buy
12 signals
Neutral
7 signals
Sell
2 signals
Overall: Neutral33% Neutral signals
IndicatorValue
RSI (14)
61.89
Stochastic %K (14, 3, 3)
85.66
CCI (20)
90.10
WPR (14)
-21.09
Momentum (10)
26.21
MFI
67.25
MACD Level (12, 26)
12.21
Bollinger Bands
$556.22 - $638.61
ATR (14)
$13.64 (2.21%)
ADX (14)
24.02
OBV
-20,673,400
Exponential Moving Averages
$522.23 - $612.59(5 indicators)
Simple Moving Averages
$490.88 - $616.22(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

TMO kicked off the day with a gentle 0.530% gap higher, setting the open at 622.29 after yesterday’s 619.01. At the open, derivatives traders in TMO are heavily hedged, with a put/call ratio of 1.80. TMO opens higher amid heavy derivatives hedging and recent market interest in forensic tech advancements.

Price Change

from $619.01 close

+$9.54

Trading Volume

Below avg (2.7M)

648.6K

vs S&P 500 Today

Strong Outperformance

+8.68%

52-Week Position

Near highs

99.4%

Updated: January 21, 2026 at 15:36 UTC

Quote Summary
OpenPrevious Close
$622.29$619.01
Day Range52 Week Range
$620.27 - $631.67$385.46 - $631.67
VolumeAvg. Volume
1.5M1.8M
Market CapP/E Ratio
$236.5B36.4